Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cell Dyscrasias”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Not applicableEnrolling By InvitationNCT04210791
What this trial is testing

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Who this might be right for
AL AmyloidosisPlasma Cell Dyscrasia
Nanjing University School of Medicine 500
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Large-scale testing (Phase 3)Active Not RecruitingNCT03480360
What this trial is testing

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
Dartmouth-Hitchcock Medical Center 21
Not applicableStudy completedNCT02274519
What this trial is testing

Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Disorder
Mayo Clinic 29
Early research (Phase 1)Looking for participantsNCT06313502
What this trial is testing

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorder
University of Arkansas 18
Not applicableLooking for participantsNCT02012699
What this trial is testing

Integrated Cancer Repository for Cancer Research

Who this might be right for
Pancreatic CancerThyroid CancerLung Cancer+47 more
University of Nebraska 999,999
Not applicableLooking for participantsNCT01408225
What this trial is testing

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

Who this might be right for
Plasma Cell DyscrasiasMonoclonal Gammopathy of Undetermined SignificanceAL Amyloidosis+1 more
Ohio State University Comprehensive Cancer Center 5,000
Not applicableUnknownNCT03405571
What this trial is testing

Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.

Who this might be right for
Multiple MyelomaVenous Thromboembolism
University of Athens 800
Not applicableStudy completedNCT05032339
What this trial is testing

Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer

Who this might be right for
Plasma Cell Disorder
Becton, Dickinson and Company 208
Early research (Phase 1)Study completedNCT00952237
What this trial is testing

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma+2 more
Dartmouth-Hitchcock Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT01816620
What this trial is testing

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

Who this might be right for
POEMS Syndrome
Peking Union Medical College Hospital 41
Not applicableLooking for participantsNCT01351545
What this trial is testing

Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Who this might be right for
Hematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets+14 more
Center for International Blood and Marrow Transplant Research 99,999
Testing effectiveness (Phase 2)Looking for participantsNCT07075510
What this trial is testing

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

Who this might be right for
Plasma Cell Disorder
University of Maryland, Baltimore 30
Testing effectiveness (Phase 2)Ended earlyNCT00942422
What this trial is testing

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
Barbara Ann Karmanos Cancer Institute 8
Not applicableWithdrawnNCT05362331
What this trial is testing

Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
LymphomaLeukemiaPlasma Cell Dyscrasia
University of California, San Francisco
Early research (Phase 1)Study completedNCT01248923
What this trial is testing

ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma, Plasma Cell Leukemia
Array Biopharma, now a wholly owned subsidiary of Pfizer 55
Not applicableNot Yet RecruitingNCT06330896
What this trial is testing

Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing

Who this might be right for
Plasma Cell Disorder
Siriraj Hospital 498
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Active Not RecruitingNCT04504825
What this trial is testing

Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

Who this might be right for
AL Amyloidosis
Alexion Pharmaceuticals, Inc. 125
Very early researchNot Yet RecruitingNCT07365059
What this trial is testing

Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders

Who this might be right for
Plasma Cell Dyscrasias
Qi deng 18
Load More Results